Epirubicin and Docetaxel as Primary Chemotherapy in Locally Advanced Breast Cancer

被引：0
|
作者：
Conti, F. [1 ]
Corsetti, S. [1 ]
Viola, G. [1 ]
Sperduti, I. [1 ]
Carpano, S. [1 ]
Pizzuti, L. [1 ]
Foggi, P. [1 ]
Perri, P. [1 ]
Anza, M. [1 ]
Toglia, G. [1 ]
Lopez, M. [1 ]
机构：
[1] Regina Elena Inst Canc Res, I-00161 Rome, Italy
来源：
ONCOLOGY | 2009年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
17
引用
收藏
页码：139 / 140
页数：2
相关论文
共 50 条
  • [41] Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial
    Schmid, P
    Krocker, J
    Schulz, CO
    Michniewicz, K
    Dieing, A
    Eggemann, H
    Heilmann, V
    Blohmer, JU
    Sezer, O
    Elling, D
    Possinger, K
    [J]. ANTI-CANCER DRUGS, 2005, 16 (01) : 21 - 29
  • [42] Primary Chemotherapy with Bevacizumab for Locally Advanced Triple Negative Breast Cancer
    Carpenter, J.
    Falkson, C.
    Nabell, L.
    De Los Santos, J.
    Krontiras, H.
    Bland, K.
    Li, Y.
    Bae, S.
    [J]. BREAST, 2023, 68 : S61 - S61
  • [43] Locally advanced breast cancer: Is PET useful for monitoring primary chemotherapy?
    Biersack, HJ
    Palmedo, H
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (11): : 1815 - 1817
  • [44] Effects of primary chemotherapy on biological parameters of locally advanced breast cancer
    Collecchi, P
    Giannessi, PG
    Baldini, E
    Naccarato, AG
    Passoni, A
    Bevilacqua, G
    Conte, PF
    [J]. BASIS FOR CANCER MANAGEMENT, 1996, 784 : 419 - 426
  • [45] Sequential epidoxorubicin and paclitaxel as primary chemotherapy for locally advanced breast cancer
    Giardina, G
    Danese, S
    Bellino, R
    Katsaros, D
    de Sanctis, C
    Durando, A
    Richiardi, G
    Arese, P
    Genta, F
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 23 - 23
  • [46] A multicenter study of epirubicin-docetaxel (ET) as primary chemotherapy for patients with inflammatory breast cancer (IBC)
    Anan, K.
    Mitsuyama, S.
    Ikejiri, K.
    Ohchi, T.
    Rai, Y.
    Oikawa, T.
    Kudaka, M.
    Nishimura, R.
    Kuroki, S.
    Tamura, K.
    [J]. BREAST, 2007, 16 : S48 - S48
  • [47] Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophoshamid followed by docetaxel in primary breast cancer
    Cramer, EM
    Moers, C
    Zarghooni, V
    Bosse, K
    Mallmann, P
    Warm, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S231 - S231
  • [48] Primary chemotherapy with docetaxel for the management of breast cancer
    Valero, V
    [J]. ONCOLOGY-NEW YORK, 2002, 16 (06): : 35 - 43
  • [49] A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer
    Villman, Kenneth
    Ohd, John F.
    Lidbrink, Elisabet
    Malmberg, Lena
    Lindh, Birgitta
    Blomqvist, Carl
    Nordgren, Hans
    Bergh, Jonas
    Bergstrom, Daniel
    Ahlgren, Johan
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (07) : 1153 - 1160
  • [50] BMI and TLC Influences Doxorubicin/Epirubicin Neoadjuvant Chemotherapy Response in Patients with Locally Advanced Breast Cancer
    Priyono, Sasongko Hadi
    Putra, Oscar Tri Joko
    Yasmina, Alfi
    Poerwosusanta, Hery
    Rahman, Eka Yudha
    Oktaviyanti, Ika Kustiyah
    [J]. MAJALAH KEDOKTERAN BANDUNG, 2022, 54 (04): : 221 - 227
12345